At Sensus Healthcare, we are devoted to making a difference in the lives of people who suffer from non-melanoma skin cancer and unsightly keloid scarring. By designing and manufacturing safe and reliable state-of-the-art Superficial Radiation Therapy technology right here in the United States, we are providing compassionate dermatologists and oncologists around the world with a non-surgical treatment option that empowers them to cure patients without compromising patient confidence, dignity or quality of life.
The compact and mobile SRT-100™ is making this standard of care accessible to more patients. Not only does the SRT meet stringent safety requirements set by the FDA, UL and ISO/CE Mark certification, it is backed by accomplished, ethical leadership and scientific case studies that are testaments to the SRT’s exceptional performance.
98.7%+
Non Reoccurrence Rate
No anesthesia, cutting, bleeding, stitching or pain
No downtime or lifestyle restrictions
Super cosmesis, no unsightly scarring
No need for post-treatment reconstructive surgeries
A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new technologies and services in many areas, including electronic brachytherapy, PET and PET/CT, SPECT, MRI, lithotripsy and digital radiography. Before joining Sensus Healthcare, Sardano held leadership and management roles at CTI Molecular Imaging, GE Medical Systems, Siemens Medical Systems, Elscint Inc and Toshiba America Medical Systems, among others.
Mr. Sosa joined Sensus as Vice President of Technology Development with extensive experience in bank alarm systems, computer graphics, asset tracking, medical devices and artificial intelligence. In his 25+ years of experience, amongst his accomplishments are the introduction and engineering of the first GPS device in the Argentina market with real time streaming video cameras for vehicles and automated asset tracking systems (founding Overmax S.A. in 2007 ). His company in the U.S. was recognized as 2016 small business of the year. He has also designed and developed in the late 90’s electroencephalography and brain mapping devices, implementing the first 3-D EEG Brain Mapping medical devices and polysomnography machines at the time. In his new position he is charged with overseeing and expanding the company’s team of engineers to provide dependable and differentiated technologies to customers and their patients. A priority focus will be on expanding the capabilities and indications of the company’s Sentinel™ technology. Sentinel provides asset management and HIPAA-compliant patient data and storage capability, and also contains the software necessary to support shared service models including direct patient billing. Mr. Sosa studied software engineering at the National University of Technology in Buenos Aires, international marketing and foreign trade at the University of Buenos Aires in Argentina
Mr. Suen brings to Sensus nearly 20 years of business development, sales and regulatory experience supporting the distribution of U.S. medical devices and other products throughout Asia and in particular China.
Most recently, he was Director, Business Development at Fosun Pharma, with responsibility for identifying complementary products to expand the Fosun/Chindex product portfolio and providing strategies for companies to enter the China market.
From 2010 to 2016 he was Senior Manager, Business Development and Regulatory at Chindex International, prior to its acquisition by Fosun Pharma. At Chindex, Mr. Suen was part of a team that initiated and managed the first robotic surgery reference center in China, and established one of the most successful da Vinci Surgical System marketing programs in the world.
From 2004 to 2010 he served as Manager, Business Development at Prosperity Link in Beijing, where he was responsible for the annual sourcing of more than $50 million in food products from the U.S.
Kenrick Anthony Spence, M.D., F.A.C.S., Medical Director and Chief Plastic Surgeon at the Hillcrest Plastic Surgery since 1999, specializes in Advanced Facial Rejuvenation, Facial Surgery and Facial Revision Surgeries, Body Contouring and Body Contouring Revisionary Surgeries. Throughout his tenure at Hillcrest Plastic Surgery, Dr. Spence has led a team comprised of Dermatologists, Plastic Surgeon, Anesthesiologist, Nurse Practitioners, Aestheticians, Registered Nurses, Medical Assistants, Surgical Technicians, Patient Care Coordinators and Administrators.
Born in London, England, of Jamaican parentage, an alumnus of Calabar High School and the University of the West Indies, Dr. Spence has been in the practice of medicine since 1990. In 1999, Dr. Spence established his private practice in Plastic and Reconstructive Surgery in Orlando, Florida. Dr. Spence’s quest to combine the artistry of plastic surgery with the aesthetic needs of each patient began while pursuing his medical career at the University Of Connecticut School Of Medicine, 1986. In 1991, at the invitation of The Saint Raphael’s Hospital, Yale University, Dr. Spence completed a five year program in general surgery achieving Board Certification in General Surgery. From there, he journeyed to his plastic surgery fellowship at the University of Texas at Galveston achieving his Board Certification in Plastic and Reconstructive Surgery.
In 2005, Dr. Spence situated his practice in the state-of-the-art facility at 130 Hillcrest Street, located on the out skirts of Downtown Orlando, conveniently located near main traffic arteries in Central Florida and close proximity to one of the country’s largest international airports. This location boasts a 6,002 square feet facility consisting of multi-facetted examination rooms, an advanced skincare center, a keloid center and a surgery center. The latter is certified by the credentialing body, American Association for Accreditation of Ambulatory Surgery Facilities, Inc. (AAAASF) since 2006. This onsite surgery center affords patients the convenience, privacy and safety for surgical procedures performed under general and local anesthesia.
Dr. Spence considers the changes in the lives of many to be the hallmark of his career. He is certified by the American Board of Plastic Surgery, a member of the American Society for Aesthetic Plastic Surgery and a Fellow of the American College of Surgeons. As a father and husband Dr. Spence brings to his practice of medicine an appreciation of life.
Voted Orlando’s best Plastic Surgeon 6 years in a row, and recognized by one of the world’s largest pharmaceutical companies as a Master Injector, Dr. Spence is a pioneer and internationally recognized as an expert in his field. Some patients refer to him as a “magician”. He has helped thousands of patients reclaim their youthful appearance and boost self-esteem.
Dr. Spence is a humanitarian at heart, proudly an active donor to Habitat for Humanity, he has provided pro-bono services for women who are victims of domestic violence and last but not least his selfless contribution of time and work associated with the Austin Smiles in El Salvador.
Dr. Spence has earned an enviable reputation with “Sculptease”, a procedure designed, developed & trademarked by him. Also developed by Dr. Spence is A.S.C.R “Aesthetic Skin Cancer Reconstruction” which is the integration and exciting blend of cosmetic and reconstructive surgery.
Dr. Michael H. Gold is the founder of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center located in Nashville, Tennessee. Dr. Gold is also Clinical Assistant Professor at Vanderbilt University School of Nursing and Adjunct Assistant Professor at Meharry Medical College, School of Medicine also in Nashville, Tennessee. He is also a Physician Assistant Student Preceptor of Wake Forest School of Medicine in Winston Salem, NC. He is a Visiting Professor of Dermatology for Huashan Hospital, Fudan University in Shanghai, China (11/2006), Guangdong Provincial People’s Hospital, Guangzhou, China, as well as Visiting Professor of Dermatology at Number One Hospital of China Medical University (11/2008) in Shenyang, China. Visiting Professor Rongjun Hospital, Jiaxing, China, 2016. Additionally, he is Visiting Professor of Plastic Surgery, First People’s Hospital of Foshan, Guangzhou, China and The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang. In addition, he is Visiting Professor of Plastic Surgery, The People’s Hospital of Hunan Province.
Dr. Gold is a board-certified dermatologist and cosmetic surgeon who oversees the various facets of the Gold Skin Care Center’s operations: a combination of medical and surgical dermatology, cosmetic dermatology, aesthetic services, and research endeavors. Dr. Gold has earned a national and international reputation for providing patients with leading-edge technological advances and has expertise in all facets of dermatology and aesthetic care. The Tennessee Clinical Research Center is one of the leading dermatologic research institutions in the U.S. Dr. Gold is the author of over 300 published scientific articles, and 35 textbook chapters. He is the editor of two textbooks on photodynamic therapy and global use of PDT. Dr. Gold works as an associate editor with the majority of dermatology journals and actively contributes to the medical literature with his colleagues from around the world. In 2016, he became the Editor-in-Chief of the Journal of Cosmetic Dermatology. Dr. Gold speaks on national and international fronts, focusing on dermatology issues related to the use of lasers and energy-based devices, as well as the use of fillers and toxins in aesthetic and cosmetic dermatology. He has spoken on Practice Management issues in dermatology for almost 30 years. He lectures in venues around the world and is a sought-after contributor to educational meetings globally.
Dr. Gold is an active member of many of the leading dermatology and laser specialty societies in the U.S. and around the world. He is the founder and past President of the Dermatologic & Aesthetic Surgery International League (DASIL), whose mission is to teach dermatology and dermatologic surgery all over the world in a non-profit setting. This society has become one of the fastest-growing international dermatologic societies because of its core beliefs of teaching and transparency. Dr. Gold oversees the DASIL meeting, which attracts 150 faculty members, and upwards of serval thousand attendees from more than 40 countries. DASIL is primed to be the international dermatologic surgery society. He is a founding member and current President of the 5-Continent-Congress, one of the leading global aesthetic congresses. These meetings held in Barcelona, attract over 150 faculty and up to 1200 attendees. It has become one of the leading aesthetic meetings in the world. In addition, Dr. Gold is the President of the Symposium for Cosmetic Advances & Laser Education (SCALE), which is part of the Tennessee Society for Laser Medicine and Surgery. The meeting, which began 12 years ago, as an effort to educate and teach the proper use of lasers and injectables in the community. Since its onset, SCALE has grown in stature and regarded as one of the most influential aesthetic and dermatology meetings in the U.S. SCALE’s base is in Nashville, Tennessee and attracts an incredible faculty year after year.
David J. Goldberg, MD, JD is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and non-invasive facial and body rejuvenation techniques. A board-certified dermatologist who has been in practice since 1985, he has treated patients and taught doctors throughout the world in the use of these cutting-edge technologies.
Under his direction, Skin Laser & Surgery Specialists of New York and New Jersey has been a pioneer in making skin laser and cosmetic dermatology technologies available to the public. Dr. Goldberg earned his medical degree from Yale University. He completed his dermatology residency and dermatologic surgical fellowship at New York University Medical Center. He is a clinical professor and former director of Mohs Surgery and Laser Research in the department of Dermatology at NY’s Icahn School of Medicine at Mount Sinai.
Dr. Goldberg has published over 160 academic papers and has contributed to over 15 academic textbooks. He has authored textbooks on laser dermatology, laser hair removal, laser facial rejuvenation, photodamaged skin, skin wrinkle fillers, acne, rosacea, unwanted fat and cellulite . He has also co-authored two books for the general public: Light Years Younger and Secrets of Great Skin. Dr. Goldberg is active in professional societies and was elected president of the American Society for Lasers in Medicine & Surgery. He has also served as chairperson of the Ethics Committees of the American Academy of Dermatology, the American Society for Lasers in Medicine and Surgery and the American Society for Dermatologic Surgery. He has sat on the board of directors of the American Academy of Dermatology, the American Society for Lasers in Medicine and Surgery, the American Society for Dermatologic Surgery and the International Society for Dermatologic Surgery. He has also served as a co-vice-president of the Skin Cancer Foundation. Dr. Goldberg was the first recipient of the prestigious Leon Goldman award, named after the founder of laser surgery.
Additionally, Dr. Goldberg was named one of the “Top Ten Laser Surgeons in the U.S.” by Self magazine, one of the “Best Doctors in America” by Woodward/White, Inc., a “Best Doctor in America” by Best Doctors Inc. and one of the “Best Dermatologists in New Jersey” by New Jersey Monthly. Dr. Goldberg has always been eager to advance the skill levels of his colleagues. He has an active fellowship Program at his practice that draws the “best of the best” dermatologists and Physician Assistants, many of whom join Skin Laser & Surgery Specialists of New York and NY and NJ after their fellowship is complete. Lastly, his legal background and expertise in Health Care Law (he has taught Health Care Law at NY’s Fordham Law School for over 15 years) puts Dr. Goldberg at the forefront in understanding the economic, legal and ethical issues of today’s health care and dermatology delivery systems.
Dr. Kevin Schewe is a Board-Certified Radiation Oncologist and a Fellow of the American College of Radiation Oncology. Dr. Schewe has devoted his 30-year medical career and practice in the fight against cancer. He currently serves as Medical Director of Radiation Oncology at the Red Rocks Medical Center in Golden, Colorado (https://radiationoncologyatredrocks.com/). The Red Rocks Radiation Oncology Center was created by Dr. Schewe and is beautifully and warmly designed to feel more like a comfortable home for cancer patients rather than a traditional medical facility.
Dr. Schewe serves as Chairman of National Cancer Survivors Day at the Red Rocks Center the first Sunday of every June and that event has become a highly-anticipated and joyful tradition in Jefferson County. He has been named to “5280 Top Docs” multiple years and is known as a strong advocate of the personalized treatment approach for each cancer patient entrusted to his care.
Dr. Schewe has also developed a premium line of skin care and cosmetic products that help to naturally heal, protect, repair and subsequently maintain not only the damaged skin of cancer patients, but also individuals who have experienced skin damage resulting from aging, dryness, UV exposure, other illnesses, and environmental pollution. These products are manufactured and sold by Dr. Schewe’s company Elite Therapeutics (https://www.elitetherapeutics.com/). Dr. Schewe also serves as Chairman of the Board of a publically-traded, microcap, renewable green-energy company called VIASPACE (https://viaspace.com/) which has a proprietary product called Giant King Grass that is a high-yielding biomass source that creates carbon-neutral bioenergy and biofuels.
Professor Emeritus of Dermatology University of Miami Miller School; Co-Director Center for Clinical and Cosmetic Research Skin and Cancer Associates, Aventura, FL Dr. Brian Berman is Professor Emeritus of Dermatology and Dermatologic Surgery at The University of Miami Miller School of Medicine and has had the honor of serving as a member of the Board of Directors and is presently Vice President-Elect of the American Academy of Dermatology and the American Academy of Dermatology Association and Vice President of the American Dermatological Association. He has served as Professor of Dermatology and Internal Medicine at the University of Miami, Medical Director for Dermatology for inpatient and outpatients at Dade County’s Jackson Memorial Hospital, Professor of Dermatology and Vice-Chairman of the Department of Dermatology at The University of California, Davis, Chief of the Dermatology Service at the VA Medical Center, Martinez, CA, and Chairman of the Department of Dermatology at The Mount Sinai Medical Center in Miami Beach, Florida. He is past President and Founder of The National Association of Veterans Affairs Dermatologists, Chaired the Dermatology Field Advisory Group for The Department of Veterans Affairs, is a member of the nominating committee of the American Dermatological Association, Treasurer of the American Cutaneous Oncology Society, and serves on the Scientific Advisory / Editorial Boards of The European Journal of Dermatology, Journal of Cosmetic Dermatology, and SKINmed, Journal of Clinical and Aesthetic Dermatology, edited The Miami Review series and was a member of the Board of Trustees of the Sulzberger Institute for Dermatologic Education.
In addition to caring for patients at Skin and Cancer Associates in Aventura, FL, Dr. Berman also attends and teaches at the Miami Veterans Affairs Medical Center. As Co-Director of the Center for Clinical and Cosmetic Research he continues his broad-based clinical research program while focusing laboratory investigations on the study of the control of scarring. He has presented at over 300 local,regional, state, national and international Dermatologic Societies and meetings. He is the author of more than 250 peer-reviewed scientific and clinical articles, chapters and books, is the recipient of the Dean’s Senior Faculty Clinical Research Award from the University of Miami School of Medicine, was bestowed the “Scientist of the Year” Award from Sigma Xi the Science and Research Honor Society and is included in U.S. News and World Report’s “Best Doctors in America”.
Ms. Cornish brings to Sensus more than a decade of experience working on Capitol Hill in several Congressional offices and as a lobbyist advising a broad range of companies in a variety of industries. Since 2016 she has served as vice president of external affairs and corporate secretary for FoodMaven Corporation, a Colorado Springs-based company that sells unsold and oversupplied food from distributors, manufacturers and producers to restaurants and institutional buyers. Since 2013 she has been an independent consultant to corporations, law firms, not-for-profit organizations and political campaigns on government relations and lobbying.
Ms. Cornish served from 2012 to 2013 as Legislative Assistant to Rep. Tim Holden of Pennsylvania, who was a member of the U.S. Committee on Agriculture from 1992 to 2014. From 2009 to 2012 while serving as Legislative Assistant to Rep. Edolphus Towns of New York, she researched and analyzed immigration, science and technology, homeland security, animal rights issues and special projects while he served as Chairman of the U.S. House Committee on Oversight and Government Reform. Earlier in her career she contributed to multiple political campaigns for candidates running for local, state and federal offices.